This unit entry is for students who completed this unit in 2016 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

PGC5010 - Infectious diseases pharmacotherapy

6 points, SCA Band 2, 0.125 EFTSL

Postgraduate - Unit

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.

Faculty

Pharmacy and Pharmaceutical Sciences

Coordinator(s)

Ms Sharmila Khumra

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Offered

Parkville

First semester 2016 (Off-campus)
Second semester 2016 (Off-campus)

Notes

Previously coded PGC6010
For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Synopsis

This unit will provide a broad overview or introduction to the treatment and management of infectious diseases. The focus will be on common infections seen in community and hospital settings, principles of microbiology and infectious diseases, antimicrobial use, and antimicrobial stewardship. The broad unit objectives are for students to develop and apply infectious diseases and antimicrobial use knowledge and skills in the care of patients, especially those with infections. These may be patients in the community or hospital settings. The knowledge and skills developed will be at a general level rather than at the level required for a specialist infectious diseases pharmacist.

Outcomes

On completion of the unit students will be able to:

Prepare and analyse treatment plans that optimise the use of anti-infectives.
Recommend approaches to manage patients requiring anti-infective therapies.
Demonstrate critical thinking, communication skills relevant to peers and patients and problem-solving, with a focus on infectious diseases related and anti-infectives related topics.

Assessment

Assignment: 30%
Contribution to on-line discussions: 50%
Submission of a learning portfolio: 20% (hurdle)

Workload requirements

Minimum total expected workload to achieve the learning outcomes for this unit is 144 hours per semester typically comprising a mixture of scheduled learning activities and independent study. The unit requires on average 10-12 hours of scheduled activities per week. Scheduled activities may include teacher directed learning, reading time, participation in tutorials or discussion groups, research and preparation for assignments.

Chief examiner(s)

Ms Sharmila Khumra

This unit applies to the following area(s) of study

Clinical pharmacy
Pharmacy practice

Prerequisites

There are no prerequisites however it is preferable for students to have completed PGC5001 Evidence based practice prior to enrolling into this unit.

Prohibitions

This unit cannot be taken with PGC5003 Patient data and pharmacotherapy 2 without prior approval from the relevant Course Director as there is significant overlap in content.